Plain-English translation of NCT06885918 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study designed to learn more about ALS and related motor neuron diseases by gathering medical information and data from people living with these conditions, as well as from people who carry genes associated with ALS but don't have symptoms yet. The study also includes healthy volunteers as a comparison group. By collecting this information over time, researchers hope to discover new ways to detect the disease earlier, develop better treatments, and create better tools to measure how patients respond to future therapies.
Right now, scientists need a better understanding of how ALS develops and progresses in different people so they can design more effective treatments. This study brings together real-world information from many patients to help identify patterns, genetic clues, and markers that could speed up the discovery of new medicines and help doctors measure whether treatments are actually working.
You likely qualify if…
You likely don't qualify if…
You would share your medical information and data with the research team, which can be done remotely—meaning from your home. The study collects both information you provide now and your medical history from the past. Depending on your group, you may be asked to provide updates about your health over time, donate blood or tissue samples for genetic testing, or answer surveys about your symptoms and experiences. The exact timeline depends on your situation, but the goal is to build a long-term picture of how ALS develops and affects different people.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States
Sponsor
ALS Therapy Development Institute
Enrollment target
~2,000 participants
Started
September 2014
Primary completion
January 2035
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Alan S Premasiri, M.S.
ALS Therapy Development Institute
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.